Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of stem cell medicine and preparation method of fusion PNV targeting ischemic myocardial vessels

A stem cell and cardiovascular technology, applied in the field of bioengineering, can solve problems such as DNA mutation, limited environmental conditions, and poor effect

Active Publication Date: 2021-05-28
高连如
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the presence of antibody FC, it is easy to be phagocytized by immune cells in the body, so the effect is poor and it is easy to stimulate the immune response
In addition, there are also studies on the method of using an external magnetic field to guide the homing of stem cells, which is limited by environmental conditions, etc.
The recent genetic modification method expresses the single-chain antibody linkage method, and there is still a risk of DNA mutation due to gene introduction into DNA
Therefore, so far, there is no safe and reliable method to solve the problem of targeted homing of exogenously infused stem cells to ischemic myocardial vessels

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of stem cell medicine and preparation method of fusion PNV targeting ischemic myocardial vessels
  • A kind of stem cell medicine and preparation method of fusion PNV targeting ischemic myocardial vessels
  • A kind of stem cell medicine and preparation method of fusion PNV targeting ischemic myocardial vessels

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0063] The platelet membrane nanovesicles were prepared by using a water-bath sonicator to process for 5 minutes under ultrasonic conditions with a frequency of 42 kHz and a power of 100 W. The presence of PNV was verified by morphological examination using dynamic light scattering (DLS) and transmission electron microscopy (TEM). Western blot, immunohistochemistry, and flow cytometry were used to identify the presence of CD42b (GPIbα), CD41 (IIb / IIIa) receptors.

[0064] The more optimal technical scheme of the present invention is conceived as follows: in order to achieve effective angiogenesis and myocardial repair, two kinds of cardiovascular precursor stem cells (APC, Flk-1+) are directly selected, and a unique microenvironment (WJMSCs) is provided for angiogenesis ), that is, the components of the extracellular matrix, thus constituting the regenerative microenvironment in which vascular precursor stem cells differentiate into blood vessels under the regulation of angiog...

Embodiment 1

[0068] The stem cell drug fused with PNV targeting ischemic myocardial vessels in this embodiment is specifically an injection. The preparation process and efficacy characteristics of the injection solution fused with PNV targeting ischemic myocardial blood vessels of the present invention will be described below in conjunction with this example.

[0069] The umbilical cord blood and umbilical cord abandoned by newborns were used as material sources, and platelets were extracted from umbilical cord blood to prepare platelet membrane nanovesicles PNV. Flk-1+ cells and umbilical artery adventitial pericyte APC were extracted from the umbilical artery adventitia, and WJMSCs derived from Huatong jelly were extracted from the Huatong jelly tissue between the umbilical artery, umbilical vein and umbilical cord adventitia. The three kinds of stem cells were mixed and cultured in proportion to obtain cardiovascular precursor stem cells CVPSCs, and then PNV was fused with CVPSCs to pre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
transmittivityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a stem cell medicine for fused PNV targeting ischemic myocardial blood vessels, which comprises cardiovascular precursor stem cells, and platelet membrane nanovesicle PNV is fused on the surface of the cardiovascular precursor stem cells. The present invention utilizes the biological characteristics of human platelet membrane glycoprotein receptors to naturally target homing to ischemic myocardium and atherosclerosis ischemic vessels, prepares platelet membrane nanovesicle PNV, and uses PNV to coat cardiovascular precursor stem cells , to make stem cell medicine. PNV not only retains the glycoprotein receptors on the platelet membrane, but can sense a variety of dangerous signal molecules, and PNV does not have the mechanism of triggering and activating coagulation. It is a natural and safe targeting navigation substance that can carry vascular precursor stem cells to target Homing to the myocardial vessels with ischemic lesions to achieve the purpose of precise repair of damaged myocardial vessels. The present invention further adopts two kinds of vascular precursor stem cells, Flk-1+ cells and arterial adventitial pericytes (APC), together with WJMSCs, which can directly differentiate into blood vessels with blood perfusion function.

Description

technical field [0001] The invention relates to the technical field of bioengineering, in particular to a stem cell medicine fused with PNV targeting ischemic myocardial vessels and a preparation method thereof. Background technique [0002] Ischemic diseases caused by vascular lesions, such as coronary heart disease, cerebral infarction, ischemic necrosis of limbs, and even eye ischemic blindness, etc., have been the top causes of death and disability in the world so far. Modern medicine has failed to fundamentally improve its prognosis with drugs, intervention, surgery, organ transplantation and other means. Stem cell regenerative medicine in the 21st century has brought new opportunities. But unfortunately, because the transplanted cells can rarely reach the diseased organ tissue, the retention time is short, and the 24-hour retention is less than 5-10%, which poses a great obstacle to the realization of stem cell repair of myocardial regeneration blood vessels. [0003...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/69A61K35/51A61K47/42A61K9/08C12N5/0775C12N5/071C12N5/078A61P9/10A61P9/00
CPCA61K9/0019A61K9/08A61K35/51A61K47/42A61K47/6901A61P9/00A61P9/10C12N5/0644C12N5/0668C12N5/069C12N2501/02C12N2501/734C12N2509/00
Inventor 高连如张宁坤
Owner 高连如
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com